Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina.

Edgar Carnero ContenttiRicardo AlonsoBerenice SilvaMarcos BurgosDarío TavoliniPablo LopezEdgardo CristianoLiliana PatruccoVerónica TkachukCarolina MainellaGisella ZangaFelisa LeguizamónGeraldine LueticEmanuel SilvaSantiago TizioMarina Alonso SerenaJuan Ignacio Rojas

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

DMF significantly reduced disease activity in PwMS from Argentina with a good safety profile in real-world settings. A significant impact on the quality of life during follow-up was found.

Keyphrases

disease activity
multiple sclerosis
rheumatoid arthritis
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis patients
ejection fraction
randomized controlled trial
newly diagnosed
ankylosing spondylitis
systematic review
juvenile idiopathic arthritis
prognostic factors